MoneyWorks4Me

Indoco Remedies gets establishment inspection report from USFDA for its Goa Plant

25 May 2016 Evaluate

Indoco Remedies has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for its sterile and solid dosages facility (Goa Plant II) situated at L-32/33/34 Verna Industrial Estate, Goa. This approval confirms the closure of inspection conducted in July, 2015.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..